Former FDA Commissioners Muse On Vaccine Surveillance – And The Next Operation Warp Speed

On the question of whether the US review of COVID vaccines is moving too slow compared to the UK, 'This is a lot of falderol,' Califf said.

Clockwise from top left: Meg Tirrell, Robert Califf, Mark McClellan, and Margaret Hamburg at the Milken Institute Future of Health Summit (screenshot)
Former FDA Commissioners discuss first COVID-19 vaccine and challenges ahead • Source: Screenshot from Milken Institute's Future of Health Summit

Immediately after the US Food and Drug Administration released its briefing document for the forthcoming advisory committee review of Pfizer Inc./BioNTech SE’s COVID-19 vaccine candidate, a panel of former FDA commissioners gave their positive take on the agency’s analysis.

Speaking at the Milken Institute’s 8 December Future of Health Summit, Mark McClellan, director of the Duke-Margolis Center for Health...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers